Information Provided By:
Fly News Breaks for November 29, 2016
Nov 29, 2016 | 07:38 EDT
Maxim analyst Gabrielle Zhou initiated SciClone with a Buy rating and $14 price target, calling it uniquely positioned as a significant specialty pharma player in the China market.
News For SCLN From the Last 2 Days
There are no results for your query SCLN